Literature DB >> 15827132

Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals.

Adrian Woolfson1, Justin Stebbing, Brian D M Tom, Kerryn J Stoner, Walter R Gilks, David P Kreil, Stephen P Mulligan, Larissa Belov, Jeremy S Chrisp, Will Errington, Adrian Wildfire, Wendy N Erber, Mark Bower, Brian Gazzard, Richard I Christopherson, Mike A Scott.   

Abstract

Cluster of differentiation (CD) antigens are expressed on cells of myeloid and lymphoid lineages. As most disease processes involve immune system activation or suppression, these antigens offer unique opportunities for monitoring host responses. Immunophenotyping using limited numbers of CD antigens enables differentiation states of immune system cells to be determined. Extended phenotyping involving parallel measurement of multiple CD antigens may help identify expression pattern signatures associated with specific disease states. To explore this possibility we have made a CD monoclonal antibody array and scanner, enabling the parallel immunophenotyping of leukocyte cell suspensions in a single and rapid analysis. To demonstrate this approach, we used the specific example of patients infected with human immunodeficiency virus type-1 (HIV-1). An invariant HIV-induced CD antigen signature has been defined that is both robust and independent of clinical outcome, composed of a unique profile of CD antigen expression levels that are both increased and decreased relative to internal controls. The results indicate that HIV-induced changes in CD antigen expression are disease specific and independent of outcome. Their invariant nature indicates an irreversible component to retroviral infection and suggests the utility of CD antigen expression patterns in other disease settings.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827132     DOI: 10.1182/blood-2004-12-4642

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.

Authors:  Pawel Ciborowski
Journal:  Biomark Med       Date:  2009-12       Impact factor: 2.851

2.  The host control of lytic and latent infection with human herpesvirus-8.

Authors:  Justin Stebbing; Brian Gazzard; Mark Bower
Journal:  J Infect Dis       Date:  2006-03-06       Impact factor: 5.226

3.  Discovery and identification of potential biomarkers of pediatric acute lymphoblastic leukemia.

Authors:  Linan Shi; Jun Zhang; Peng Wu; Kai Feng; Jing Li; Zhensheng Xie; Peng Xue; Tanxi Cai; Ziyou Cui; Xiulan Chen; Junjie Hou; Jianzhong Zhang; Fuquan Yang
Journal:  Proteome Sci       Date:  2009-03-16       Impact factor: 2.480

4.  Longitudinal microarray analysis of cell surface antigens on peripheral blood mononuclear cells from HIV+ individuals on highly active antiretroviral therapy.

Authors:  Jing Qin Wu; Wayne B Dyer; Jeremy Chrisp; Larissa Belov; Bin Wang; Nitin K Saksena
Journal:  Retrovirology       Date:  2008-03-04       Impact factor: 4.602

5.  Antibody microarray analysis of cell surface antigens on CD4+ and CD8+ T cells from HIV+ individuals correlates with disease stages.

Authors:  Jing Qin Wu; Bin Wang; Larissa Belov; Jeremy Chrisp; Jenny Learmont; Wayne B Dyer; John Zaunders; Anthony L Cunningham; Dominic E Dwyer; Nitin K Saksena
Journal:  Retrovirology       Date:  2007-11-26       Impact factor: 4.602

6.  Characterization of the membrane proteome and N-glycoproteome in BV-2 mouse microglia by liquid chromatography-tandem mass spectrometry.

Authors:  Dohyun Han; Sungyoon Moon; Yikwon Kim; Hophil Min; Youngsoo Kim
Journal:  BMC Genomics       Date:  2014-02-04       Impact factor: 3.969

7.  Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.

Authors:  Kimberley L Kaufman; Swetlana Mactier; Nicola J Armstrong; Duthika Mallawaaratchy; Scott N Byrne; Lauren E Haydu; Valerie Jakrot; John F Thompson; Graham J Mann; Richard A Scolyer; Richard I Christopherson
Journal:  Clin Exp Metastasis       Date:  2014-01-17       Impact factor: 5.150

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.